Jump to content
Company database

Boehringer Ingelheim Pharma GmbH & Co. KG

The Boehringer Ingelheim group is one of the world’s 20 leading pharmaceutical companies. Head-quartered in Ingelheim, Germany, it operates globally with 142 affiliates in 50 countries and more than 41,500 employees. Since it was founded in 1885, the family-owned company has been committed for 125 years to researching, developing, manufacturing and marketing novel products of high therapeutic value for human and veterinary medicine.

Today, Boehringer Ingelheim is one of the world’s leading companies for contract development and manufacture of biopharmaceuticals. All types of services from mammalian cell line or microbial strain development to final drug production can be delivered within a one-stop-shop concept. Boehringer Ingelheim delivers services for pre-clinical development up to global market supply with a strong commitment to its customers at its manufacturing facilities for mammalian cell culture and microbial fermentation. Boehringer Ingelheim has brought 18 molecules to market and has many years of expe-rience in multiple molecule classes such as monoclonal antibodies, recombinant proteins, interferons, enzymes, fusion molecules and plasmid DNA. Furthermore, high-titer platform technologies for new antibody mimetic formats such as scaffold proteins and antibody fragments are available for the manu-facture of customer products.

Biotech Companies, Pharmaceutical Companies, Analytics, DNA/RNA, Proteins/Peptides, Therapeutics, Contract Manufacturing/OEM, Biotech Services, Cells/Cell Lines, Biopharmaceuticals, Biosimilars, Industrial Biotech
Website address: https://www.bio-pro.de/en/service/details